Code Snippets
curl "https://financialdata.net/api/v1/short-interest?identifier=GILD&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/short-interest?identifier=GILD&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/short-interest?identifier=GILD&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "GILD",
"title_of_security": "Gilead Sciences, Inc. Common S",
"market_code": "NNM",
"settlement_date": "2026-09-30",
"shorted_securities": 21828725,
"previous_shorted_securities": 18304875,
"change_in_shorted_securities": 3523850,
"percentage_change_in_shorted_securities": 19.25,
"average_daily_volume": 6503853,
"days_to_cover": 3.36,
"is_stock_split": false
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security. (e.g., MSFT) |
| offset | integer | (Optional) The initial position of the record subset, which indicates how many records to skip. Defaults to 0. (e.g., 100) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
Short interest represents the number of shares of a company that are currently sold short and have not yet been covered. The short interest ratio, also known as days to cover, represents the number of days it would take for all short-sold shares to be covered or repurchased in the market. Our API provides short interest data for over 15,000 securities. There is a limit of 100 records per API call.
Company Profile
GILEAD SCIENCES, INC.
NASDAQ: GILD- Market Cap:$103.20B
- ISIN:US3755581036
- Fiscal Year End:12/31
- CEO:Daniel O'Day
- Employees:17000
Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.